Peptides DB
Research-centric peptide and protocol reference hub
Study 1 of 9GHRP-6 literatureeuropepmc · Meta-analysis2026

Global disparities in association between leisure-time physical activity and chronic musculoskeletal pain: A systematic review and meta-analysis.

Leisure-time physical activity is inversely associated with chronic musculoskeletal pain, but the clinical significance of this finding is questionable due to small effect sizes.

Read at europepmcAdd to compare

Where it sits

this study against the rest of the ghrp-6 corpus
0
Preclinical
6
Observational
0
Open-label
1
Randomised
2
Reviews · this one

Summary and findings

This systematic review and meta-analysis examined the association between leisure-time physical activity (LTPA) and chronic musculoskeletal pain (CMSP) across 119 studies. The overall odds ratio (OR) for the association was 0.78 (95% CI: 0.70-0.87), indicating a negative association, but clinical significance was not established (Cohen's d = -0.137).

How much of this paper we could read: full text read (0.80). We had a clear abstract, so the summary below closely tracks the paper. What this means →
Overall OR for LTPA and CMSP was 0.78 (95% CI: 0.70-0.87, I2 = 99.5%) with no clinical significance (d = -0.137).2026

Abstract

The authors’ words, as europepmc supplied them

<h4>Background</h4>Previous studies have extensively investigated the association between leisure-time physical activity (LTPA) and chronic musculoskeletal pain (CMSP). However, the results have been inconsistent. It is not known whether the differences in the association between LTPA and CMSP are due to underlying factors such as demographic patterns, geographical characteristics, and location(s) of pain.<h4>Methods</h4>The systematic review and meta-analysis was conducted to assess global disparities in association between LTPA and CMSP<b>.</b> PubMed, EMBASE, MEDLINE, and Web of Science were searched for observational studies examining LTPA and the prevalence or incidence of CMSP in the general population. The systematic review with quality assessment using the JBI checklist and the Newcastle-Ottawa Scale was followed by a random-effects meta-analysis, including subgroup analysis using the following variables: sex, age group, geographical regions and location(s) of pain. Clinical significance of the pooled odds ratio (OR) was assessed using Cohen's d and risk of publication bias was assessed using Egger's test, funnel plot and trim-and-fill analysis.<h4>Results</h4>Across 119 studies, the overall OR for the association between LTPA and CMSP averaged 0.78 (95% CI: 0.70-0.87, I2 = 99.5%) with no clinical significance (d = -0.137). Differences between genders were insignificant. Among age subgroups, adults and middle-aged/older adults showed a negative association between LTPA and CMSP (OR = 0.62, 95% CI: 0.47-0.82). Pain locations with reduced odds included unspecified pain locations (OR = 0.73, 95% CI: 0.62-0.86) and lower back (OR = 0.82, 95% CI: 0.69-0.98). Geographic subgroups with negative LTPA-CMSP associations included high-income countries (OR = 0.78, 95% CI: 0.70-0.88), the continents of North and South America and Europe, and the regions of Northern and Western Europe. The differences between continents and between subcontinental regions were both significant (<i>p</i> = 0.0211 and <i>p</i> = 0.0260, respectively), suggesting an influence of sociocultural factors in addition to income level.<h4>Conclusions</h4>LTPA was inversely associated with CMSP, especially in selected populations and pain locations. This association could be due to underlying factors, such as local factors that characterize LTPA in different countries. These findings suggest that the benefits of LTPA cannot be considered universally applicable. Locally and regionally tailored interventions should be developed, taking into account place-specific structural, economic and social characteristics.

Background

Not reported in abstract.

Methods

Not reported in abstract.

Results

Not reported in abstract.

Interpretation

Not reported in abstract.

Key findings

  • Not reported in abstract.
  • Not reported in abstract.
  • Not reported in abstract.

Limitations

  • Not reported in abstract.
  • Not reported in abstract.
  • Not reported in abstract.

Elsewhere in the GHRP-6 corpus

CGHRELIN IMPAIRS EMBRYO DEVELOPMENT AFTER OVARIAN HYPERSTIMULATION.The Journal of endocrinology · 2026 · Delay in embryo development at GD 3.5 reversed by (D-Lys3)-GHRP-6.AnimalAPhase III Open-Label, Randomized Clinical Trial of Epidermal Growth Factor and Growth Hormone Releasing Hexapeptide in Acute Ischemic Stroke.Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia · 2026 · mRS at 6 months for severe-stroke patients (NIHSS≥15) treated with EGF+GHRP6 was 2.6 (95%CI: 1.3-3.8) vs Control 4.7 (95%CI: 2.6-6); p=0.03.HumanDInforming policy through evidence: A scoping review of factors that influence enrolment in community-based health insurance in East Africa.europepmc · 2026BMental health and legal statuses along the path to citizenship: A qualitative study of minority ethnic urban dwellers in Chiang Mai, Thailand.europepmc · 2026 · Not reported in abstract.HumanDDeveloping an approach to estimate the number of road traffic crashes at the national level using media-reported data.europepmc · 2026 · R² of 0.93 for training dataBAssociations between environmental exposure, lifestyle, and the risk of respiratory infections among 67890 adults: A population-based cohort analysis using UK Biobank data.europepmc · 2026 · HR=0.93, 95% CI: 0.88-0.99 for higher greenspace percentage within a 300 m buffer.Human